Explore

Trendline Trendline
Turn Therapeutics Advances GX-03 in Phase 2 Trial for Atopic Dermatitis with Financial Backing

Turn Therapeutics Advances GX-03 in Phase 2 Trial for Atopic Dermatitis with Financial Backing

Turn Therapeutics Advances GX-03 in Phase 2 Trial for Atopic Dermatitis with Financial Backing
Trendline Trendline
Enanta Pharmaceuticals Reports Decreased Net Loss Amid Financial Results for Q2 2026

Enanta Pharmaceuticals Reports Decreased Net Loss Amid Financial Results for Q2 2026

Enanta Pharmaceuticals Reports Decreased Net Loss Amid Financial Results for Q2 2026
Trendline Trendline
Agenus Inc Reports Significant Revenue Growth and Profit in Q1 2026

Agenus Inc Reports Significant Revenue Growth and Profit in Q1 2026

Agenus Inc Reports Significant Revenue Growth and Profit in Q1 2026
Trendline Trendline
Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call

Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call

Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call
Trendline Trendline
Veradermics Reports Q1 2026 Financial Results and Clinical Progress in Hair Loss Treatment

Veradermics Reports Q1 2026 Financial Results and Clinical Progress in Hair Loss Treatment

Veradermics Reports Q1 2026 Financial Results and Clinical Progress in Hair Loss Treatment
Trendline Trendline
Lantern Pharma to Announce Q1 2026 Financial Results, Highlighting AI-Driven Oncology Developments

Lantern Pharma to Announce Q1 2026 Financial Results, Highlighting AI-Driven Oncology Developments

Lantern Pharma to Announce Q1 2026 Financial Results, Highlighting AI-Driven Oncology Developments
Trendline Trendline
AN2 Therapeutics Reports Q1 2026 Financial Results and Pipeline Updates

AN2 Therapeutics Reports Q1 2026 Financial Results and Pipeline Updates

AN2 Therapeutics Reports Q1 2026 Financial Results and Pipeline Updates
Trendline Trendline
AN2 Therapeutics Reports Q1 2026 Financial Results and Advances Clinical Programs

AN2 Therapeutics Reports Q1 2026 Financial Results and Advances Clinical Programs

AN2 Therapeutics Reports Q1 2026 Financial Results and Advances Clinical Programs
Trendline Trendline
Omeros Corporation to Release First Quarter 2026 Financial Results and Host Conference Call

Omeros Corporation to Release First Quarter 2026 Financial Results and Host Conference Call

Omeros Corporation to Release First Quarter 2026 Financial Results and Host Conference Call
Trendline Trendline
Enanta Pharmaceuticals Reports Q2 2026 Financial Results Highlighting Revenue Growth and Strategic Developments

Enanta Pharmaceuticals Reports Q2 2026 Financial Results Highlighting Revenue Growth and Strategic Developments

Enanta Pharmaceuticals Reports Q2 2026 Financial Results Highlighting Revenue Growth and Strategic Developments
Trendline Trendline
Coya Therapeutics Reports Financial Results and Advances ALS Treatment

Coya Therapeutics Reports Financial Results and Advances ALS Treatment

Coya Therapeutics Reports Financial Results and Advances ALS Treatment
Trendline Trendline
Lantern Pharma to Announce Q1 2026 Financial Results Amid AI-Driven Oncology Developments

Lantern Pharma to Announce Q1 2026 Financial Results Amid AI-Driven Oncology Developments

Lantern Pharma to Announce Q1 2026 Financial Results Amid AI-Driven Oncology Developments